we have studied the ability of interferon alfa-2b ( intron a ) to prolong remissions induced by busulfan ( myleran ) in patients with chronic granulocytic leukemia ( cgl ) .
C0021735
interferon alfa-2b
C0023473
chronic granulocytic leukemia